News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 226
- Sources here
- 17
- Companies here
- 8
Active search
226 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Should Customers Bancorp’s Q2 2026 Earnings Beat and Buyback Shift the Outlook for CUBI Investors?
Customers Bancorp, Inc. has now reported its Q2 2026 results, with net interest income rising to US$193.37 million and net income to US$71.56 million, alongside unaudited quarterly net charge-offs of US$14.58 million and completion of a US$49.08 million share buyback covering 2.09% of shares. …
Atomera Inc (ATOM) Institutional Confidence
Atomera Inc (ATOM) currently holds an institutional shareholding score of 3.00, placing it 76th out of 105 in the Semiconductors & Semiconductor Equipment industry. The institutional shareholding proportion has decreased by 20.23% quarter-over-quarter to 31.72%. Bill Nygren, with OAKMX, is the largest institutional shareholder, …
Atomera Inc|Price:5.190|Chg%:-0.390
Atomera Inc. is a semiconductor company focused on developing, commercializing, and licensing its Mears Silicon Technology (MST). MST is a thin film of reengineered silicon designed to modify and enhance semiconductor properties for various applications. The company's stock symbol is ATOM, and it is …
Atomera Inc (ATOM) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Atomera Inc (ATOM), noting its current valuation score of 8.17 and ranking within the Semiconductors & Semiconductor Equipment industry. It highlights the company's current P/E ratio of -7.92, indicating a significant deviation from its recent highs and …
Form 4 Omeros Corporation For: 24 July By Investing.com
This article announces the filing of Form 4 for Omeros Corporation (OMER) for July 24th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company's …
Biomerica, Inc. Revenue Breakdown – NASDAQ:BMRA
This article provides a revenue breakdown for Biomerica, Inc. (NASDAQ: BMRA), highlighting its financial performance by segment and region. The greatest contribution to revenue came from Asia, accounting for $1.72 million last year. The article also mentions the company's previous year's performance in Asia …
Customers Bancorp Inc (CUBI) Q2 2026 Earnings Call Highlights: Record Growth in Loans and ...
This article first appeared on GuruFocus. Total Loans: Grew 4% in the quarter and 17% year over year to $18 billion. Total Deposits: Increased by over $140 million to a record $21.7 billion. Non-Interest-Bearing Deposits: Reached a record $6.9 billion, 32% of total deposits. …
Customers Bancorp targets low-40s efficiency ratio run rate in 2027 as cubiX real estate payments aims for 20% of units
Earnings Call Insights: Customers Bancorp (CUBI) Q2 2026 MANAGEMENT VIEW * “Total loans grew 4% in the quarter and 17% year-over-year to a record $18 billion,” “total deposits grew over $140 million to a record $21.7 billion,” and “noninterest-bearing deposits hit a second consecutive …
Biomerica Inc (BMRA) Institutional Confidence
The article provides an overview of Biomerica Inc.'s (BMRA) institutional confidence score and shareholder activity as of July 24, 2026. It details the shares held and percentage change for key individuals and institutional investors, such as Zackary S. Irani, Allen Barbieri, and BlackRock Institutional …
Here's What Key Metrics Tell Us About Customers Bancorp (CUBI) Q2 Earnings
Customers Bancorp (CUBI) reported $227.41 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 10.2%. EPS of $2.05 for the same period compares to $1.80 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $229.77 …
GRUPO COMERCIAL CHEDRAUI, S.A.B. DE C.V. SECOND QUARTER 2026 RESULTS
MEXICO CITY, July 22, 2026 /PRNewswire/ -- Grupo Comercial Chedraui, S.A.B. de C.V. reports its 2026 second-quarter results. All figures are shown in nominal terms and are presented in accordance with Financial Reporting Standards (IAS 34) for Interim Financial Reporting. 2Q'26 Highlights: Same Store …
Customers Bancorp (NYSE:CUBI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings
Customers Bancorp (CUBI) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $1.8 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Customers Bancorp Reports Results for Second Quarter 2026
WEST READING, Pa., July 23, 2026--(BUSINESS WIRE)--Customers Bancorp, Inc. (NYSE:CUBI): Second Quarter 2026 Highlights Q2 2026 net income available to common shareholders was $71.6 million, or $2.05 per diluted share; ROAA was 1.13% and ROCE was 13.22%. Q2 2026 core earnings*1 were $71.5 million, …
Enterprise value to EBIT forward of Atomera Incorporated – NASDAQ:ATOM
This article focuses on the "Enterprise value to EBIT forward" metric for Atomera Incorporated (NASDAQ: ATOM). It presents this financial data point within the context of TradingView's platform, indicating that the market for ATOM was closed with no trades. The content is primarily a …
Omeros stock trades around small-cap biotech levels as narsoziumab and OMS906 shape the pipeline out
Omeros Corporation, a small-cap biotech, is valued based on its legacy revenue from Omidria and the potential of its pipeline drugs narsoziumab and OMS906. While the company consistently reports operating losses due to high R&D investments, Omidria provides foundational revenue and experience, with significant …
OMER6080787 Bond Risk Profile
This page provides a risk profile for the OMER6080787 bond, issued by Omeros Corporation with a 9.5% coupon maturing on June 15, 2029. It outlines key metrics for credit risk assessment, including the bond's security level and issuer rating. Additionally, it offers access to …
OMER6080787 Bond Coupon Profile — Rate & Payments
This article provides the bond coupon profile for Omeros Corporation's OMER6080787 bond. It details that the bond has a current coupon rate of 9.50% and the next interest payment is scheduled for December 15, 2026. The article highlights the importance of understanding coupon data …
Customers Bancorp (CUBI) Reports Q2: Everything You Need To Know Ahead Of Earnings
Customers Bancorp (CUBI) Reports Q2: Everything You Need To Know Ahead Of Earnings Regional banking company Customers Bancorp (NYSE:CUBI) will be reporting results this Thursday after market close. Here's what you need to know. Customers Bancorp beat analysts' revenue expectations last quarter, reporting revenues …
Atomera Plans Aug. 4 Webinar to Discuss Second-Quarter Results
Atomera (NASDAQ: ATOM) announced it will release its second-quarter 2026 financial results after market close on Tuesday, August 4, 2026. The company will also host a live Zoom video webinar at 2:00 p.m. Pacific / 5:00 p.m. Eastern on the same day to discuss …
Omeros faces securities fraud probe after EMA rejects key drug application, stock drops 19%.
Pomerantz LLP is investigating Omeros Corporation for potential securities fraud after the European Medicines Agency (EMA) issued a negative opinion on its drug narsoplimab, causing a 19.12% stock drop on June 26, 2026. The probe is focused on unlawful business practices by Omeros and …
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Atomera Incorporated (NASDAQ: ATOM) will release its second quarter 2026 financial results after market close on Tuesday, August 4, 2026. The company will host a live video Zoom webinar on the same day at 2:00 p.m. Pacific Time to discuss the results, which can …
Law firm probes Omeros over stock drop after EM...
Pomerantz LLP is investigating Omeros Corporation for potential securities fraud after the European Medicines Agency's negative opinion on their drug narsoplimab caused a nearly 20% stock drop on June 26, 2026. The investigation aims to determine if the company or its executives engaged in …
Atomera (NASDAQ:ATOM) Share Price Crosses Below 50-Day Moving Average - Should You Sell?
Atomera (NASDAQ:ATOM) shares have fallen below their 50-day moving average, signaling continued weakness and negative sentiment. The company reported a wider-than-expected quarterly loss and minimal revenue, alongside insider stock sales. Institutional ownership remains notable, but analysts largely recommend a "Sell" for ATOM.
Earnings update coming: Customers Bancorp to unveil Q2 2026 results July 24
Customers Bancorp, Inc. (NYSE: CUBI) will host a webcast on Friday, July 24, 2026, at 9:00 AM EST to discuss its second-quarter 2026 earnings. The webcast will feature President & CEO Sam Sidhu and CFO Mark McCollom, with the earnings press release issued market …
Agencia Comercial Spirits Ltd Announces Agreements for Indonesia AI Data Center Construction, Network Infrastructure Procurement and Maintenance Services
Agencia Comercial Spirits Ltd, a whisky importer, is expanding into AI computing infrastructure in Indonesia with agreements for data center construction, network procurement, and maintenance services totaling around $61.1 million. While diversifying beyond its core whisky business, the company acknowledges significant risks regarding project …
Agencia Comercial Spirits Ltd Announces Entry into Construction, Network Infrastructure and Maintenance Agreements for Indonesia Ai Computing Deployment
Agencia Comercial Spirits Ltd. has announced that its subsidiaries have entered into agreements for the construction of a data center, procurement of network infrastructure, and provision of technical support and maintenance services for its planned AI computing infrastructure expansion in Indonesia. The agreements include …
Atomera Inc (ATOM) Q3 2025 Earnings Report - Results, Call & Slides
Atomera Inc (ATOM) released its Q3 2025 earnings report, missing analyst expectations for both EPS and revenue. The company reported an actual EPS of -$0.17 against a consensus of -$0.14, and actual revenue of $11.00K compared to an expected $100.00K, representing a 50.00% year-over-year …
OMER6081715 Bond Coupon Profile — Rate & Payments
This article provides the coupon profile for the Omeros Corporation bond OMER6081715, detailing its interest rate and payment schedule. The bond has a current coupon rate of 9.50%, with the next interest payment planned for December 15, 2026. The article highlights the importance of …
Bronstein, Gewirtz & Grossman, LLC Is Investigating Omeros Corporation (OMER) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Omeros Corporation (OMER) after the company announced a negative opinion from the CHMP regarding its marketing authorization application for narsoplimab. This news led to a significant drop in Omeros's stock …